Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
12. 78
+0.12
+0.9479%
$
340.69M Market Cap
- P/E Ratio
0.01% Div Yield
82,200 Volume
-2.95 Eps
$ 12.66
Previous Close
Add Transaction
Day Range
12.45 13.26
Year Range
9.85 16.76
Want to track BNTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Benitec Biopharma Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Didric Cederholm
Didric Cederholm Lion Point Capital LP
62,000 $648,900 $795,460 $146,560 22.59%
Joseph Castro
Joseph Castro Nuveen LLC
41,814 $465,037.24 $538,819.39 $73,782.15 15.87%
RO
Regan O'Neill Burkehill Global Management LP
150,000 $2.02M $1.93M -$93,000 -4.6%
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
8 $85 $103.6 $18.6 21.88%
Kevin Kroskey
Kevin Kroskey True Wealth Design LLC
1 $11 $13.02 $2.02 18.36%
AA
Andrew Alkon EntryPoint Capital, LLC
24,322 $259,029 $312,078.01 $53,049.01 20.48%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
6,806 $75,869.7 $86,027.84 $10,158.14 13.39%
Scott Schroeder
Scott Schroeder Longaeva Partners LP
125,000 $1.68M $1.62M -$63,750 -3.79%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
18,307 $246,595.37 $232,498.9 -$14,096.47 -5.72%
Infinitum Asset Management LLC
Infinitum Asset Management LLC Infinitum Asset Management LLC
923,006 $12.13M $11.78M -$351,643.06 -2.9%